MedPath

Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Periodontitis.

Not Applicable
Completed
Conditions
Atherosclerosis
Periodontitis
Interventions
Procedure: Non-surgical periodontal treatment
Registration Number
NCT05906797
Lead Sponsor
University of Catania
Brief Summary

A double-blind randomized-controlled clinical trial is conducted in order to evaluate the impact of non-surgical periodontal treatment on endothelial dysfunction parameters in subjects with periodontitis and without any cardiovascular disease.

Detailed Description

A double-blind randomized-controlled clinical trial is conducted in order to evaluate the impact of non-surgical periodontal treatment on endothelial dysfunction parameters in subjects with periodontitis and without any cardiovascular disease.

60 patients: 30 with periodontitis and 30 with healthy controls and without periodontitis history.

All the patients are assessed for clinical, periodontal, blood and non-invasive ultrasound cardiovascular parameters. Measurements are taken before and after initial periodontal treatment in the periodontal subjects.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Clinically diagnosed with periodontitis according to the EFP/AAP 2017 criteria.
Exclusion Criteria
  • Periodontal treatment, antibiotics, NSAIDs, immunosuppressants during the last 6 months.
  • Pregnancy.
  • Cardiovascular Diseases.

HEALTHY GROUP

Inclusion Criteria:

  • Clinically diagnosed with healthy periodontum withouth periodontitis history according to the EFP/AAP 2017 criteria.

Exclusion Criteria:

  • Scaling, antibiotics, NSAIDs, immunosuppressants during the last 6 months.
  • Pregnancy.
  • Cardiovascular Diseases.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PeriodontitisNon-surgical periodontal treatmentSubjects diagnosed with periodontitis according to the most recent international guidelines and without cardiovascular diseases.
Primary Outcome Measures
NameTimeMethod
Pulse Wave Velocity carotid-femoral (PWV-CR)8 weeks

The speed of pulse wave propagation between carotid-radial sites

Pulse Wave Velocity carotid-femoral (PWV-CF)8 weeks

The speed of pulse wave propagation between carotid-femoral sites

Carotid Intima-Media Thickness (CIMT)8 weeks

The thickness of the carotid intima and media

Distensibility Coefficient (DC)8 weeks

The relative change in luminal area during systole for a given pressure change (pulsed pressure), will be calculated assuming the lumen to be circular.

Advanced Glycation End products (AGEs)8 weeks

A group of endogenous heterogeneous compounds that are constantly formed under physiological conditions with prooxidant and cytotoxic properties. Measurements are performed by fluorescence spectroscopy technique.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

AOU Policlinico G. Rodolico

🇮🇹

Catania, Italy

© Copyright 2025. All Rights Reserved by MedPath